Naturally Inspired | Scientifically Defined

Specialist in plant derived cell signalling small molecules to address
challenging medical conditions for humans and companion animals

QBiotics prepares for a new capital raise

29 October 2018

QBiotics Group Limited has lodged a board-approved prospectus with the Australian corporate regulator the Australian Securities and Investments Commission (ASIC) on 26 October 2018.  ASIC will review the prospectus over the next 7-14 days.  For the protection of all shareholders the company has halted the Off Market Trading in shares during this prospectus review period, to ensure all investors can be fully informed. A draft of the prospectus (without an application form) can be obtained now from Once approved by ASIC the final prospectus will be made available to shareholders on or before 16 November 2018.